Pharmacovigilance Risk Assessment Committee (PRAC): 25-29 September 2017

• Date:
  Lunes, 25 Septiembre 2017, Todo el día
• Lugar:
  European Medicines Agency, Amsterdam, the Netherlands

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Documents

Minutes of the PRAC meeting 25-29 September 2017

Adopted Reference Number: EMA/PRAC/782068/2017

Agenda - PRAC draft agenda of meeting 25-29 September 2017

Draft Reference Number: EMA/PRAC/634126/2017

Agenda - Public hearing: Valproate

Adopted

Summary of the EMA public hearing on valproate in pregnancy

Public hearing on valproate - Written interventions

Reference Number: EMA/645752/2017

Public hearing on Valproate - Summary of safety concerns and list of questions for the public hearing on Valproate

Multimedia